Methods of treating multiple sclerosis using STRO-1+ and TNAP+ multipotential cells
AssigneeMesoblast, Inc.
InventorClaude Bernard
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a method for treating an inflammatory neurological disease comprising administering a population of cells enriched for STRO-1+ cells and/or progeny thereof and/or soluble factors derived therefrom.
Claims9
A method for treating a subject with multiple sclerosis, the method comprising administering to the subject a population of cells enriched for STRO-1+ TNAP+ multipotential cells in an amount effective to treat the subject.
A method for treating a subject with multiple sclerosis, the method comprising administering to the subject a population of cells enriched for STRO-1+ TNAP+ multipotential cells such that at least 5% of the cells are STRO-1+ TNAP+ multipotential cells so as to treat the subject.
Dependencies are inferred from the claim text.